MBTPS1 and coronary artery disorder: The results showed that the levels of non-HDL-bound S1P increased significantly with the enhancement of CCS score compared with controls without symptoms, supporting the hypothesis that non-HDL-bound plasma S1P may serve as a novel biomarker for CAD [232,233,234].